• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy
    Subscribe to $COYA

    Coya Therapeutics Inc.

    Subscribe to $COYA
    $COYA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    IPO Year: 2022

    Exchange: NASDAQ

    Recent Analyst Ratings for Coya Therapeutics Inc.

    DatePrice TargetRatingAnalyst
    12/4/2024$15.00Buy
    D. Boral Capital
    See more ratings

    Coya Therapeutics Inc. Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • SEC Form 4 filed by Director Weinand Dieter

      4 - Coya Therapeutics, Inc. (0001835022) (Issuer)

      2/25/25 9:30:04 PM ET
      $COYA
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • SEC Form 4 filed by Director Ross Wilbur L Jr

      4 - Coya Therapeutics, Inc. (0001835022) (Issuer)

      2/25/25 9:30:03 PM ET
      $COYA
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • SEC Form 4 filed by Director Lee Ann

      4 - Coya Therapeutics, Inc. (0001835022) (Issuer)

      2/25/25 9:30:08 PM ET
      $COYA
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • SEC Form 4 filed by Director Goldstein Dov A Md

      4 - Coya Therapeutics, Inc. (0001835022) (Issuer)

      2/25/25 9:30:05 PM ET
      $COYA
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • SEC Form 4 filed by Director Villalobos Anabella

      4 - Coya Therapeutics, Inc. (0001835022) (Issuer)

      2/25/25 9:30:07 PM ET
      $COYA
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • SEC Form 4 filed by Chief Medical Officer Grossman Fred

      4 - Coya Therapeutics, Inc. (0001835022) (Issuer)

      1/13/25 8:00:05 AM ET
      $COYA
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • SEC Form 4 filed by Chief Executive Officer Swaminathan Arun

      4 - Coya Therapeutics, Inc. (0001835022) (Issuer)

      1/13/25 8:00:06 AM ET
      $COYA
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • SEC Form 4 filed by Director Berman Howard

      4 - Coya Therapeutics, Inc. (0001835022) (Issuer)

      1/13/25 8:00:03 AM ET
      $COYA
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • SEC Form 4 filed by Chief Financial Officer Snyder David S

      4 - Coya Therapeutics, Inc. (0001835022) (Issuer)

      1/13/25 8:00:07 AM ET
      $COYA
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • SEC Form 4 filed by Director Villalobos Anabella

      4 - Coya Therapeutics, Inc. (0001835022) (Issuer)

      1/3/25 9:30:20 PM ET
      $COYA
      Biotechnology: Pharmaceutical Preparations
      Health Care